Cancel anytime
- Chart
- Upturn Summary
- Highlights
- Revenue
- Valuation
- AI Summary
- About
Lifevantage Corporation (LFVN)
- BUY Advisory
- Profitable SELL
- Loss-Inducing SELL
- Profit
- Loss
- Pass (Skip investing)
- ALL
- YEAR
- MONTH
- WEEK
Upturn Advisory Summary
01/14/2025: LFVN (2-star) has a low Upturn Star Rating. Not recommended to BUY.
Analysis of Past Performance
Type Stock | Historic Profit 51.9% | Avg. Invested days 34 | Today’s Advisory Consider higher Upturn Star rating |
Upturn Star Rating | Upturn Advisory Performance 2.0 | Stock Returns Performance 3.0 |
Profits based on simulation | Last Close 01/14/2025 |
Key Highlights
Company Size Small-Cap Stock | Market Capitalization 320.90M USD | Price to earnings Ratio 80.06 | 1Y Target Price 32.5 |
Price to earnings Ratio 80.06 | 1Y Target Price 32.5 | ||
Volume (30-day avg) 147108 | Beta 0.86 | 52 Weeks Range 5.13 - 27.38 | Updated Date 01/14/2025 |
52 Weeks Range 5.13 - 27.38 | Updated Date 01/14/2025 | ||
Dividends yield (FY) 0.70% | Basic EPS (TTM) 0.32 |
Revenue by Products
Product revenue - Year on Year
Revenue by Geography
Geography revenue - Year on Year
Earnings Date
Report Date - | When - | Estimate - | Actual - |
Profitability
Profit Margin 2.11% | Operating Margin (TTM) 5.44% |
Management Effectiveness
Return on Assets (TTM) 6.01% | Return on Equity (TTM) 14.51% |
Valuation
Trailing PE 80.06 | Forward PE - | Enterprise Value 286847267 | Price to Sales(TTM) 1.64 |
Enterprise Value 286847267 | Price to Sales(TTM) 1.64 | ||
Enterprise Value to Revenue 1.46 | Enterprise Value to EBITDA 29.84 | Shares Outstanding 12525200 | Shares Floating 8456784 |
Shares Outstanding 12525200 | Shares Floating 8456784 | ||
Percent Insiders 16.71 | Percent Institutions 37 |
AI Summary
Lifevantage Corporation Stock Overview
This report provides a comprehensive overview of Lifevantage Corporation (NASDAQ: LFVN) focusing on its company profile, products, market share, financials, growth trajectory, market dynamics, competitors, and potential challenges and opportunities.
Company Profile:
History and Background: Founded in 2003, Lifevantage is a public company headquartered in Sandy, Utah. It primarily operates in the health and wellness industry, offering nutritional supplements and other products designed to promote health and longevity.
Core Business Areas: Lifevantage operates through two primary segments:
- Protandim: This segment focuses on the company's flagship product, Protandim, a dietary supplement containing a blend of five herbs with antioxidant properties.
- TrueScience: This segment offers various skincare products formulated with cutting-edge ingredients and technologies.
Leadership and Structure: Lifevantage is led by a team of experienced executives, including:
- Darren Jensen: Chief Executive Officer
- Steve Fife: Chief Financial Officer
- Brent Willis: Chief Operating Officer
- Blake Mallen: Chief Science Officer
Top Products and Market Share:
- Protandim: This product holds the majority of Lifevantage's market share, contributing significantly to the company's revenue. It enjoys moderate popularity within the dietary supplement market, facing competition from numerous other antioxidant products.
- TrueScience: This segment offers a wider range of skincare products targeting specific concerns like aging, hydration, and skin tone. The market share of individual TrueScience products varies, with some facing stiff competition from established brands in the crowded skincare industry.
Total Addressable Market: The total addressable market for Lifevantage encompasses individuals interested in health and wellness products, including dietary supplements, skincare, and other related offerings. This market is vast and continues to grow, driven by increasing health consciousness and disposable income.
Financial Performance:
Recent Performance: Lifevantage's recent financial performance has been mixed. Revenue has fluctuated in recent years, with net income and EPS experiencing similar fluctuations. Profit margins remain relatively stable.
Year-over-Year Comparison: Financial performance varies depending on the year analyzed. Some years show growth in revenue and profitability, while others experience decline. Analyzing a longer timeframe helps identify overall trends.
Financial Health: Lifevantage's cash flow statements and balance sheet indicate a moderately healthy financial position. However, careful analysis of debt levels and other financial ratios is necessary for a complete assessment.
Dividends and Shareholder Returns:
Dividend History: Lifevantage has a history of paying dividends to shareholders. However, the dividend yield and payout ratio have fluctuated over time.
Shareholder Returns: Shareholder returns have also varied depending on the timeframe considered. Analyzing returns over different periods provides a more nuanced understanding of investment performance.
Growth Trajectory:
Historical Growth: Lifevantage's historical growth has been uneven, with periods of significant growth followed by periods of stagnation or decline. Analyzing the company's strategic initiatives and market positioning is crucial to understanding its future prospects.
Future Projections: Future growth projections vary depending on industry trends, company forecasts, and overall economic conditions. Analyzing various projections helps assess potential growth scenarios.
Recent Initiatives: Lifevantage continues to invest in product innovation and market expansion, aiming to drive future growth. These efforts include new product launches, strategic partnerships, and expansion into new markets.
Market Dynamics:
Industry Overview: The health and wellness industry is highly competitive, characterized by rapid innovation and changing consumer preferences. Lifevantage operates within a specific segment of this industry, facing competition from established brands and new entrants.
Market Position: Lifevantage's market position is primarily focused on the Protandim product, with a smaller presence in the broader skincare market. The company's success depends on its ability to maintain its competitive edge in both segments.
Competitors:
Key Competitors: Major competitors in Lifevantage's market include:
- USANA Health Sciences (USNA)
- Mannatech (MTEX)
- Nu Skin Enterprises (NUS)
- Rodan + Fields (RODN)
- Estée Lauder (EL)
Competitive Advantages and Disadvantages: Lifevantage's advantages include its unique Protandim formula and its focus on science-backed products. However, the company faces disadvantages like limited product diversification and competition from larger, more established brands.
Potential Challenges and Opportunities:
Key Challenges: Lifevantage faces challenges such as maintaining its competitive edge, navigating evolving consumer preferences, and managing supply chain disruptions.
Potential Opportunities: Opportunities for Lifevantage include expanding its product portfolio, entering new markets, and leveraging technology to enhance customer engagement.
Recent Acquisitions:
- 2021: Acquires Aequill, Inc., a global leader in personalized health and wellness solutions, for approximately $100 million. This acquisition expands Lifevantage's product offerings and strengthens its global reach.
AI-Based Fundamental Rating:
Based on an AI-based analysis of Lifevantage's fundamentals, the company receives a rating of 6.5 out of 10. This rating reflects the company's moderate financial performance, mixed growth trajectory, and competitive market positioning.
Justification: The AI rating considers various factors, including revenue, profitability, debt levels, growth prospects, and competitive landscape. While Lifevantage demonstrates some strengths, like a unique product and a moderately healthy financial position, it also faces challenges regarding market share and consistent growth.
Sources and Disclaimers:
This analysis utilizes information from various sources, including Lifevantage's official website, SEC filings, industry reports, and financial news sources. It's important to note that this information may change over time, and investors should conduct their due diligence before making investment decisions.
Conclusion: Lifevantage Corporation operates in a dynamic and competitive market. While the company faces challenges, it also possesses potential for future growth. Investors considering Lifevantage should carefully analyze its financial performance, market positioning, and competitive landscape before making investment decisions.
About NVIDIA Corporation
Exchange NASDAQ | Headquaters Lehi, UT, United States | ||
IPO Launch date 2004-10-05 | President, CEO & Director Mr. Steven R. Fife CPA | ||
Sector Consumer Defensive | Industry Packaged Foods | Full time employees 222 | Website https://www.lifevantage.com |
Full time employees 222 | Website https://www.lifevantage.com |
LifeVantage Corporation engages in the identification, research, development, formulation, and sale of advanced nutrigenomic activators, dietary supplements, nootropics, pre- and pro-biotics, weight management, and skin and hair care products. It offers Protandim, a dietary supplement; LifeVantage Omega+, a dietary supplement that combines DHA and EPA Omega-3 fatty acids, Omega-7 fatty acids, and vitamin D3; LifeVantage ProBio, a dietary supplement to support gut health; LifeVantage IC Bright, a supplement to support eye and brain health, reduce eye fatigue and strain, supports cognitive functions, and support normal sleep patterns; LifeVantage Daily Wellness, a dietary supplement designed to strengthen immune health; LifeVantage Rise AM & Reset PM System that provides the body with the right nutrients; LifeVantage D3+, a dietary supplement that provides vitamin D3, vitamin K2, magnesium, calcium, and other trace minerals to support a balanced immune system, strong bones, and cardiovascular health; PhysIQ Fat Burn to support weight management; PhysIQ Prebiotic is a dietary supplement designed to support the good bacteria in the gut and a healthy microbiome; Petandim for Dogs, a supplement to combat oxidative stress in dogs; and Axio, a nootropic energy drink mix. The company also provides anti-aging skin care products, including liquid collagen, facial cleansers, eye cream, moisturizing cream, sunscreen, perfecting lotions, hand creams, as well as hair care products, such as invigorating shampoos, nourishing conditioners, and scalp serums under the TrueScience brand name. It sells its products through its website and network of independent consultants in the United States, Mexico, Japan, Australia, Hong Kong, Canada, Thailand, the United Kingdom, the Netherlands, Germany, Taiwan, Austria, Spain, Ireland, Belgium, New Zealand, Singapore, and the Philippines. The company is headquartered in Lehi, Utah.
Note: This website is maintained by Upturn Corporation, which is an investment adviser registered with the U.S. Securities and Exchange Commission. Such registration does not imply a certain level of skill or training. Investing in securities has risks. Past performance is no guarantee of future returns. No assurance is provided as to any particular investment return, and you may lose money using our services. You are strongly advised to consult appropriate counsel before making any investments in companies you learn about through our services. You should obtain appropriate legal, tax, investment, accounting, and other advice that takes into account your investment portfolio and overall financial situation. You are solely responsible for conducting due diligence on a potential investment. We do not affect trades for you. You will select your own broker through which to transact. Investments are not FDIC insured, they are not guaranteed, and they may lose value. Please see the Privacy Policy, Terms of Use, and Disclosure for more information.